| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |